Alveolar Osteitis MeSH Unique ID: D004368 Dry Sockets Socket, Dry Sockets, Dry Alveolar Osteitis Alveolar Osteitides Osteitides, Alveolar Osteitis, Alveolar Alveolar Periostitis Alveolar Periostitides Periostitides, Alveolar Periostitis, Alveolar Alveolitis Sicca Dolorosa Alveolalgia Alveolalgias
Conditions
Interventions
Patients in this group will be irrigated with saline solution using a 10cc 21Gauge syringe.,In this group, ErCrYSGG Waterlase, 2780nm wavelength, class IV laser with fiber optic transmission system in
Active Comparator No treatment,Active Comparator Device
Saline Irrigation,Laser Irrigation
Sponsors
Oguzcan Goksu
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Patients aged between 18 and 65 years 2) Patients without systemic diseases (classified as ASA I or ASA II according to the American Society of Anesthesiologists classification) 3) Patients who have not used steroids or anti-inflammatory drugs in the last 3 months 4) Patients showing no signs of active infection around the extraction socket 5) Patients who have not received any previous treatment for alveolar osteitis 6) Patients with adequate mental, physical abilities, and knowledge level to comply with the study protocol 7) Patients who do not use tobacco, tobacco products, or alcohol 8) Patients diagnosed with alveolar osteitis developing between the 3rd and 5th day after tooth extraction
Exclusion criteria
Exclusion criteria: 1) Patients younger than 18 or older than 65 years 2) Patients with systemic diseases (classified as ASA III, ASA IV, or ASA V according to the American Society of Anesthesiologists classification) 3) Patients who have used steroids or anti-inflammatory drugs in the last 3 months 4) Patients with active infection at the extraction socket site 5) Patients who have already received treatment for alveolar osteitis 6) Patients lacking the mental, physical abilities, or knowledge level required to comply with the study protocol 7) Patients who use tobacco, tobacco products, or alcohol 8) Patients using oral contraceptives 9) Pregnant patients 10) Breastfeeding patients 11) Patients who cannot provide informed consent personally 12) Patients with missing examination or follow-up records
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Postoperative 1., 3., 7., and 14. days VAS | — |
Secondary
| Measure | Time frame |
|---|---|
| tissue healing Postoperative 1., 3., 7., and 14. days Landry, Howley and Turnbull Index | — |
Countries
Turkey
Contacts
Public ContactOguzcan Goksu
Akdeniz University
Outcome results
None listed